Corbus Pharmaceuticals Holdings, Inc. SEC filings CRBP
Corbus Pharmaceuticals Holdings, Inc. has 808 filings in SEC EDGAR's recent list, going back to Jan 10, 2014. Its latest annual report, Form ARS, was filed on Apr 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Nov 2, 2026 | Oct 29, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 2, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 29, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 15, 2026 | Oct 15, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 30, 2026 | — |
| 4 | Insider transaction | Sep 15, 2026 | Sep 14, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 14, 2026 | Sep 14, 2026 |
| 4 | Insider transaction | Aug 17, 2026 | Aug 16, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 4 | Insider transaction | Aug 12, 2026 | Aug 11, 2026 |
| 4 | Insider transaction | Aug 10, 2026 | Aug 7, 2026 |
| 4 | Insider transaction | Aug 10, 2026 | Aug 7, 2026 |
| 424B5 | Prospectus supplement | Aug 7, 2026 | — |
| 144 | Notice of proposed sale | Aug 7, 2026 | — |
| 144 | Notice of proposed sale | Aug 7, 2026 | — |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2026 | Aug 6, 2026 |
| 3 | Initial insider ownership | Aug 4, 2026 | Aug 3, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 27, 2026 | — |
| 144 | Notice of proposed sale | Jul 27, 2026 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 6, 2026 | Jul 2, 2026 |
| S-8 | Employee stock plan registration | Jun 17, 2026 | — |
| 4 | Insider transaction | Jun 11, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 11, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 11, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 2, 2026 |
| S-8 | Employee stock plan registration | May 29, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 26, 2026 | May 26, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 21, 2026 |
| 3 | Initial insider ownership | May 22, 2026 | May 21, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 19, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 19, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 19, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 19, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 19, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 19, 2026 |
| 3 | Initial insider ownership | May 21, 2026 | May 13, 2026 |
| 8-K |
Current report
Material agreement, Officer or director change, Regulation FD disclosure
|
May 21, 2026 | May 19, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 14, 2026 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Regulation FD disclosure
|
May 14, 2026 | May 13, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 12, 2026 | May 12, 2026 |
| DEFA14A | Additional proxy material | Apr 16, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Apr 16, 2026 | Apr 15, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 14, 2026 | Apr 14, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Apr 7, 2026 | Apr 1, 2026 |
| ARS | Annual report to shareholders | Apr 2, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 2, 2026 | — |
| DEF 14A | Proxy statement | Apr 2, 2026 | Apr 1, 2026 |
| 424B3 | Prospectus | Mar 25, 2026 | — |
| EFFECT | Filing | Mar 20, 2026 | — |
| CORRESP | Letter to the SEC | Mar 18, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 13, 2026 | — |
| S-3 | Shelf registration | Mar 11, 2026 | — |
| 10-K | Annual report | Mar 9, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 9, 2026 | Mar 9, 2026 |
| 4 | Insider transaction | Mar 4, 2026 | Mar 2, 2026 |
| 144 | Notice of proposed sale | Mar 2, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 25, 2026 | Feb 25, 2026 |
| 4 | Insider transaction | Feb 18, 2026 | Feb 17, 2026 |
| 4 | Insider transaction | Feb 18, 2026 | Feb 13, 2026 |
| 4 | Insider transaction | Feb 18, 2026 | Feb 13, 2026 |
| 144 | Notice of proposed sale | Feb 13, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 10, 2026 | — |
| 4 | Insider transaction | Feb 4, 2026 | Feb 3, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 3, 2026 |
| 4 | Insider transaction | Jan 16, 2026 | Jan 14, 2026 |
| 4 | Insider transaction | Jan 16, 2026 | Jan 14, 2026 |
| 4 | Insider transaction | Jan 16, 2026 | Jan 14, 2026 |
| 4 | Insider transaction | Jan 16, 2026 | Jan 14, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 16, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Officer or director change
|
Dec 18, 2025 | Dec 12, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Dec 15, 2025 | — |
| 4 | Insider transaction | Dec 15, 2025 | Dec 11, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 11, 2025 | Dec 11, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 12, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Nov 3, 2025 | Oct 30, 2025 |
| 424B5 | Prospectus supplement | Nov 3, 2025 | — |
| 8-K |
Current report
Other events
|
Oct 30, 2025 | Oct 30, 2025 |
| 424B5 | Prospectus supplement | Oct 30, 2025 | — |
| 4 | Insider transaction | Oct 27, 2025 | Oct 24, 2025 |
| 4 | Insider transaction | Oct 27, 2025 | Oct 24, 2025 |
| 144 | Notice of proposed sale | Oct 24, 2025 | — |
| 144 | Notice of proposed sale | Oct 24, 2025 | — |
| 4 | Insider transaction | Oct 21, 2025 | Oct 20, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 20, 2025 | Oct 18, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 16, 2025 | Sep 16, 2025 |
| 10-Q | Quarterly report | Aug 5, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 5, 2025 | Aug 5, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 29, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 16, 2025 | — |
| 4 | Insider transaction | Jun 2, 2025 | May 30, 2025 |
| 4 | Insider transaction | Jun 2, 2025 | May 30, 2025 |
| 4 | Insider transaction | Jun 2, 2025 | May 30, 2025 |
| 4 | Insider transaction | Jun 2, 2025 | May 30, 2025 |
| 4 | Insider transaction | Jun 2, 2025 | May 30, 2025 |
| 4 | Insider transaction | Jun 2, 2025 | May 30, 2025 |
| 8-K |
Current report
Shareholder vote results, Other events
|
May 19, 2025 | May 15, 2025 |
| 10-Q | Quarterly report | May 6, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 6, 2025 | May 6, 2025 |
| ARS | Annual report to shareholders | Apr 1, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 1, 2025 | — |
| DEF 14A | Proxy statement | Apr 1, 2025 | May 15, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 21, 2025 | Mar 20, 2025 |
| 3 | Initial insider ownership | Mar 18, 2025 | Mar 13, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 18, 2025 | Mar 13, 2025 |
| 10-K | Annual report | Mar 11, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 11, 2025 | Mar 11, 2025 |
| 4 | Insider transaction | Mar 7, 2025 | Mar 6, 2025 |
| 144 | Notice of proposed sale | Mar 6, 2025 | — |
| 4 | Insider transaction | Feb 18, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 14, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 144 | Notice of proposed sale | Feb 14, 2025 | — |
| 144 | Notice of proposed sale | Feb 14, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 14, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Jan 31, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Jan 31, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Jan 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 3, 2024 | Dec 3, 2024 |
| 8-K |
Current report
Other events
|
Nov 15, 2024 | Nov 15, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 8, 2024 | — |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 7, 2024 | Nov 7, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 4, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 4, 2024 | Nov 4, 2024 |
| SC 13G | Ownership over 5% (passive) | Oct 22, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Oct 15, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Oct 11, 2024 | — |
| 4 | Insider transaction | Sep 24, 2024 | Sep 20, 2024 |
| 144 | Notice of proposed sale | Sep 4, 2024 | — |
| 8-K |
Current report
Other events
|
Sep 3, 2024 | Aug 29, 2024 |
| 4 | Insider transaction | Aug 20, 2024 | Aug 16, 2024 |
| 3 | Initial insider ownership | Aug 20, 2024 | Aug 16, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 20, 2024 | Aug 15, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 6, 2024 | Aug 6, 2024 |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2024 | Aug 6, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Other events
|
Jun 17, 2024 | Jun 14, 2024 |
| 144 | Notice of proposed sale | Jun 14, 2024 | — |
| 144 | Notice of proposed sale | Jun 14, 2024 | — |
| 4 | Insider transaction | Jun 14, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 3, 2024 | May 30, 2024 |
| 4 | Insider transaction | Jun 3, 2024 | May 30, 2024 |
| 4 | Insider transaction | Jun 3, 2024 | May 30, 2024 |
| 4 | Insider transaction | Jun 3, 2024 | May 30, 2024 |
| 4 | Insider transaction | Jun 3, 2024 | May 30, 2024 |
| 4 | Insider transaction | Jun 3, 2024 | May 30, 2024 |
| 4 | Insider transaction | Jun 3, 2024 | May 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 3, 2024 | Jun 1, 2024 |
| S-8 | Employee stock plan registration | May 31, 2024 | — |
| 4 | Insider transaction | May 20, 2024 | May 16, 2024 |
| 4 | Insider transaction | May 20, 2024 | May 16, 2024 |
| 4 | Insider transaction | May 20, 2024 | May 16, 2024 |
| 4 | Insider transaction | May 20, 2024 | May 16, 2024 |
| 4 | Insider transaction | May 20, 2024 | May 16, 2024 |
| 4 | Insider transaction | May 20, 2024 | May 16, 2024 |
| 4 | Insider transaction | May 20, 2024 | May 16, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 20, 2024 | May 16, 2024 |
| 8-K |
Current report
Other events
|
May 9, 2024 | May 9, 2024 |
| 144 | Notice of proposed sale | May 8, 2024 | — |
| 10-Q | Quarterly report | May 7, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 7, 2024 | May 7, 2024 |
| 4 | Insider transaction | Apr 11, 2024 | Apr 10, 2024 |
| DEFA14A | Additional proxy material | Apr 10, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Apr 10, 2024 | Apr 10, 2024 |
| ARS | Annual report to shareholders | Apr 2, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 2, 2024 | — |
| DEF 14A | Proxy statement | Apr 2, 2024 | Mar 29, 2024 |
| PRE 14A | Preliminary proxy statement | Mar 22, 2024 | May 16, 2024 |
| EFFECT | Filing | Mar 20, 2024 | — |
| 8-K |
Current report
Other events
|
Mar 20, 2024 | Mar 20, 2024 |
| 10-K/A | Amended annual report | Mar 20, 2024 | Dec 31, 2023 |
| 424B3 | Prospectus | Mar 20, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Mar 18, 2024 | — |
| CORRESP | Letter to the SEC | Mar 18, 2024 | — |
| UPLOAD | Letter from the SEC | Mar 15, 2024 | — |
| S-3 | Shelf registration | Mar 13, 2024 | — |
| 10-K | Annual report | Mar 12, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 12, 2024 | Mar 12, 2024 |
| 4 | Insider transaction | Mar 11, 2024 | Mar 7, 2024 |
| 4 | Insider transaction | Feb 29, 2024 | Feb 27, 2024 |
| 3 | Initial insider ownership | Feb 29, 2024 | Feb 27, 2024 |
| SC 13G | Ownership over 5% (passive) | Feb 28, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CRBP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Norwood, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1595097
- Former names
- SAV Acquisition Corp (until Jan 10, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.